CIDE Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CIDE Antibodies for advanced research in the field of cell death and metabolism. CIDE Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CIDE proteins regulate apoptosis and lipid metabolism, making them significant in understanding various physiological and pathological processes. The involvement of CIDE proteins in cellular energy homeostasis and programmed cell death highlights their importance in diseases such as obesity, diabetes, and cancer. Research focused on CIDE proteins can reveal crucial mechanisms of cell survival and death, leading to potential therapeutic interventions. Understanding CIDE protein function has become increasingly important in metabolic research and disease treatment strategies. Investigating CIDE-mediated pathways provides valuable insights into cellular processes and potential drug targets. CIDE research supported by Santa Cruz Biotechnology monoclonal antibodies continues to advance scientific understanding of metabolic disorders and cell death mechanisms.